GBI Research Market Research Reports

Title published price

Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by ongoing Transition from Anti-resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness

By GBI Research

Summary Osteoporosis is a “silent epidemic” and as per the WHO declarations, it is a priority health issue. Osteoporosis is a disruption of bone architecture and decrease in bone mass, leading to a number of co ...

01-Aug-2018 $4995

Respiratory Tract Infections Drug Development Pipeline Review, 2018

By GBI Research

Respiratory Tract Infections Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for respiratory tract infections. It provides comprehensive information on the therapeuti ...

31-Jul-2018 $3995

Mucopolysaccharidosis Disorders Drug Development Pipeline Review, 2018

By GBI Research

Mucopolysaccharidosis Disorders Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for mucopolysaccharidosis disorders, a group of inherited lysosomal storage disorders. ...

30-Jul-2018 $3995

Diarrhea and Constipation Drug Development Pipeline Review, 2018

By GBI Research

Diarrhea and Constipation Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for diarrhea and constipation. It provides comprehensive information on the therapeutics und ...

30-Jul-2018 $3995

Frontier Pharma: Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer

By GBI Research

Frontier Pharma: Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer Summary Breast cancer remains a major global healthcare concern despi ...

01-Jul-2018 $6995

Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline

By GBI Research

Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline Summary Cancer immunotherapy, which can predominantly be classed as a form ...

01-Jul-2018 $4995

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018

By GBI Research

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for diabetes and associated metabolic conditions. It provides comprehensi ...

29-Jun-2018 $3995

Menopausal Disorders Drug Development Pipeline Review, 2018

By GBI Research

Menopausal Disorders Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for menopausal disorders. It provides comprehensive information on the therapeutics under develop ...

29-Jun-2018 $3995

Hepatitis Drug Development Pipeline Review, 2018

By GBI Research

Hepatitis Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for hepatitis infections. It provides comprehensive information on the therapeutics under development and ke ...

29-Jun-2018 $3995

Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market

By GBI Research

Psoriasis is a common, chronic inflammatory skin condition affecting around 2-3% of the world’s population. While the main cause of psoriasis remains uncertain, immunologic, genetic, and environmental factors appear to play a role. Common sy ...

01-Jun-2018 $4995

Mosquito-borne Diseases Drug Development Pipeline Review, 2018

By GBI Research

Mosquito-borne Diseases Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for mosquito-borne diseases and comprehensive information on the therapeutics under developmen ...

24-May-2018 $3995

Ocular Cancer Drug Development Pipeline Review, 2018

By GBI Research

Ocular Cancer Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for ocular cancer and comprehensive information on the therapeutics under development and key players in ...

23-May-2018 $3995

Inflammatory Skin Diseases Drug Development Pipeline Review, 2018

By GBI Research

Inflammatory Skin Diseases Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for inflammatory skin disorders and comprehensive information on the therapeutics under dev ...

22-May-2018 $3995

Frontier Pharma: Schizophrenia - Diverse First-in-Class Pipeline Shows Promise for Treatment of Negative and Cognitive Symptoms

By GBI Research

Frontier Pharma: Schizophrenia - Diverse First-in-Class Pipeline Shows Promise for Treatment of Negative and Cognitive Symptoms Summary Schizophrenia is a chronic mental disorder that affects 1% of the population - equivalen ...

01-May-2018 $6995

Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence

By GBI Research

Breast cancer is the second most common cancer in the world overall, and the most common cancer in women. When diagnosed at a very early stage, the prognosis is positive, with a five-year survival rate of nearly 90%. However, in the later stages o ...

01-May-2018 $4995

Influenza A Viral Infections Drug Development Pipeline Review, 2018

By GBI Research

This report provides an overview of the pipeline landscape for influenza A viral infections. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for influenza A H3N2, H1N1 ...

30-Apr-2018 $3995

Cognitive Impairment Disorders Drug Development Pipeline Review, 2018

By GBI Research

Cognitive Impairment Disorders Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for cognitive impairment disorders. It provides comprehensive information on the therap ...

01-Apr-2018 $3995

Frontier Pharma: Type 2 Diabetes Mellitus - Therapies Targeting GPCRs and Protein Kinases Dominate Pipeline, with Strong Repositioning Opportunities into Associated Areas, Including Obesity and Cardiovascular Disease

By GBI Research

Frontier Pharma: Type 2 Diabetes Mellitus - Therapies Targeting GPCRs and Protein Kinases Dominate Pipeline, with Strong Repositioning Opportunities into Associated Areas, Including Obesity and Cardiovascular Disease Summary ...

01-Apr-2018 $6995

HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies

By GBI Research

Hereditary Angioedema (HAE) is a rare genetic disorder caused by a lack of a sufficient amount of a protein called C1 esterase inhibitor (C1-INH), which plays a role in immune system function, blood clotting, and bleeding. With insufficient C1-INH ...

31-Mar-2018 $4995

Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs

By GBI Research

Summary Immune-mediated inflammatory diseases are a common set of chronic disorders that affect 5-7% of people in Western populations. Although they are often disparate in terms of their symptoms and key p ...

31-Mar-2018 $4995